enteroviru
coxsackieviru
common
caus
hand
foot
mouth
diseas
sever
infect
may
associ
lifethreaten
complic
howev
pathogen
mechan
underli
sever
clinic
patholog
featur
remain
incomplet
understood
lipid
known
play
critic
role
multipl
stage
viru
replic
cycl
specif
lipid
profil
induc
upon
viru
infect
requir
optim
viru
replic
perturb
host
cell
lipidom
profil
upon
enteroviru
infect
fulli
character
end
perform
ultrahigh
perform
liquid
chromatographyelectrospray
ionizationquadrupoletim
flightmass
spectrometri
uplcesiqtofm
base
lipidom
character
chang
host
lipidom
upon
infect
result
reveal
lipid
within
lipid
class
significantli
perturb
infect
four
polyunsatur
fatti
acid
pufa
name
arachidon
acid
aa
docosahexaeno
acid
dha
docosapentaeno
acid
dpa
eicosapentaeno
acid
epa
consist
upregul
upon
infect
importantli
exogen
suppli
three
four
pufa
includ
aa
dha
epa
cell
cultur
significantli
reduc
replic
taken
togeth
result
suggest
enterovirus
might
specif
modul
host
lipid
pathway
optim
viru
replic
excess
exogen
addit
lipid
disrupt
delic
homeostat
state
could
prevent
effici
viral
replic
precis
manipul
host
lipid
profil
might
potenti
hosttarget
antivir
strategi
enteroviru
infect
enterovirus
nonenvelop
virus
belong
genu
enteroviru
famili
picornavirida
associ
import
human
mammalian
diseas
enterovirus
nonseg
singlestrand
positivesens
rna
genom
measur
around
kilobas
speci
genu
enteroviru
name
enteroviru
l
rhinoviru
c
among
member
speci
enteroviru
enteroviru
coxsackieviru
two
common
caus
recurr
commun
outbreak
hand
foot
mouth
diseas
hfmd
among
children
worldwid
particularli
asiapacif
region
exampl
mainland
china
recurr
larg
outbreak
hfmd
involv
patient
report
sinc
outbreak
infect
sever
fatal
case
also
report
malaysia
hong
kong
japan
singapor
taiwan
thailand
vietnam
australia
importantli
sever
infect
associ
lifethreaten
complic
asept
mening
enceph
myocard
noncardiogen
pulmonari
edema
respiratori
failur
death
howev
pathogen
mechan
underli
clinic
patholog
featur
incomplet
understood
lipid
known
play
crucial
role
multipl
stage
viral
replic
cycl
virus
includ
enterovirus
may
util
lipid
receptor
entri
cofactor
viru
entri
build
block
regul
viral
replic
complex
well
signal
factor
facilit
cellular
distribut
viral
protein
traffick
assembl
releas
viru
particl
interestingli
virus
requir
repertoir
host
lipid
complet
life
cycl
inhibit
key
lipogenesi
enzym
downregul
viru
replic
howev
suppli
excess
lipid
similarli
perturb
effici
viru
replic
togeth
evid
suggest
complet
lipid
landscap
induc
upon
viru
infect
requir
optim
viru
replic
perturb
host
cell
lipidom
profil
upon
enteroviru
infect
fulli
character
studi
first
establish
robust
platform
lipidom
analysi
enteroviru
infect
appli
platform
perform
unbias
analysi
host
lipidom
chang
induc
rhabdomyosarcoma
rd
cell
found
enterovirus
perturb
express
multipl
lipid
class
host
cell
infect
importantli
exogen
suppli
select
fatti
acid
significantli
inhibit
viral
replic
find
provid
novel
insight
role
lipid
pathogenesi
antivir
treatment
enteroviru
infect
establish
reliabl
platform
lipidom
analysi
first
valid
lipid
coverag
liquid
chromatographymass
spectrometri
lcm
system
stabil
appli
repres
lipid
intern
standard
cover
lipid
class
current
studi
tabl
retent
time
shift
mass
accuraci
lipid
standard
rang
ppm
respect
coeffici
variat
cv
intern
standard
cell
sampl
qc
sampl
lower
respect
result
indic
oper
repeat
satisfactori
evalu
stabil
analyt
batch
cv
valu
mass
featur
qualiti
control
qc
sampl
calcul
total
featur
measur
neg
posit
mode
respect
exhibit
cv
valu
indic
analyt
batch
stabl
minim
variat
taken
togeth
result
show
analyt
method
reliabl
observ
differ
among
test
sampl
repres
true
physiolog
differ
rather
technic
error
investig
host
cell
lipid
metabol
perturb
upon
enteroviru
infect
compar
lipidom
profil
rd
cell
infect
mockinfect
cell
lipid
featur
mass
spectrometri
ms
featur
list
first
normal
dna
concentr
sampl
normal
list
import
metaboanalyst
simcap
softwar
analysi
partial
least
squar
discrimin
analysi
plsda
score
plot
neg
posit
mode
appli
visual
distribut
lipid
discrimin
virusinfect
mockinfect
sampl
shown
figur
lipid
profil
three
type
sampl
clearli
separ
neg
posit
mode
indic
mani
lipid
ms
featur
exhibit
obviou
chang
ms
featur
contribut
discrimin
pattern
among
three
group
plsda
pattern
recognit
addit
princip
compon
analysi
pca
score
plot
appli
visual
distribut
lipid
related
virusinfect
mockinfect
sampl
shown
figur
cell
sampl
distribut
statist
confid
region
base
hotel
test
pca
result
show
cell
sampl
current
studi
outlier
character
lipidom
chang
upon
infect
heat
map
construct
base
lipid
ms
featur
list
shown
figur
differ
pattern
lipidom
chang
observ
neg
mode
figur
posit
mode
figur
lipid
profil
three
type
sampl
less
differ
neg
mode
figur
lipid
profil
sampl
markedli
differ
mockinfect
sampl
posit
mode
figur
common
pattern
two
detect
mode
lipid
ms
featur
cell
higher
abund
mockinfect
control
select
significantli
perturb
lipid
featur
lipid
profil
rd
cell
univari
multivari
data
analys
base
lipid
ms
featur
list
perform
univari
analysi
total
featur
known
unknown
lipid
featur
detect
neg
mode
featur
known
unknown
lipid
featur
detect
posit
mode
appli
select
criteria
adjust
p
total
significantli
differ
featur
neg
mode
featur
posit
mode
identifi
vs
mockinfect
sampl
total
significantli
differ
featur
neg
mode
featur
posit
mode
identifi
vs
mockinfect
sampl
multivari
analysi
crossvalid
paramet
satisfactori
oplsda
model
tabl
model
also
satisfi
permut
test
time
base
plsda
model
result
sampl
compar
mockinfect
sampl
figur
overal
result
demonstr
valid
statist
model
reliabl
identifi
significantli
perturb
lipid
featur
compar
lipidom
analysi
virusinfect
mockinfect
sampl
three
group
plsda
pattern
recognit
addit
princip
compon
analysi
pca
score
plot
appli
visual
distribut
lipid
related
virusinfect
mockinfect
sampl
shown
figur
cell
sampl
distribut
statist
confid
region
base
hotel
test
pca
result
show
cell
sampl
current
studi
outlier
construct
base
lipid
ms
featur
list
shown
figur
differ
pattern
lipidom
chang
observ
neg
mode
figur
posit
mode
figur
lipid
profil
three
type
sampl
less
differ
neg
mode
figur
lipid
profil
sampl
markedli
differ
mockinfect
sampl
posit
mode
figur
common
pattern
two
detect
mode
lipid
ms
featur
cell
higher
abund
mockinfect
control
select
significantli
perturb
lipid
featur
lipid
profil
rd
cell
univari
multivari
data
analys
base
lipid
ms
featur
list
perform
univari
analysi
total
featur
known
unknown
lipid
featur
detect
neg
mode
featur
known
unknown
lipid
featur
detect
posit
mode
appli
select
criteria
adjust
p
total
significantli
differ
featur
neg
mode
order
identifi
specif
lipid
chang
infect
signific
lipid
featur
group
annot
use
msdial
softwar
potenti
precursor
ion
use
perform
msm
experi
obtain
fragment
pattern
msm
spectra
repres
lipid
shown
figur
total
significantli
chang
lipid
identifi
three
group
sampl
compar
pair
lipid
includ
belong
phospholipid
glycerolipid
fatti
acyl
sphingolipid
categori
detail
inform
identifi
lipid
list
tabl
lipid
belong
lipid
class
includ
cardiolipin
cl
diacylglycerol
dag
etherlink
lysophosphatidylcholin
etherlpc
etherlink
lysophosphatidylethanolamin
etherlp
etherlink
phosphatidylethanolamin
etherp
free
fatti
acid
ffa
lysophosphatidylcholin
lpc
lysophosphatidylethanolamin
lpe
phosphatidylcholin
pc
sphingomyelin
sm
triacylglycerol
tag
figur
among
tag
etherp
ffa
three
perturb
lipid
class
upon
infect
character
signific
lipid
perturb
infect
next
compar
direct
magnitud
statist
signific
lipid
chang
rd
cell
mockinfect
cell
fourhour
post
infect
hpi
figur
cell
exhibit
total
significantli
perturb
lipid
belong
four
lipid
class
includ
ffa
dag
lpc
tag
significantli
upregul
hpi
figur
tabl
cell
exhibit
total
perturb
lipid
belong
lipid
class
includ
cl
ffa
etherlpc
etherlp
etherp
lpc
lpe
tag
pc
sm
except
pc
significantli
upregul
infect
among
identifi
lipid
class
ffa
lpc
tag
show
consist
upregul
grouptogroup
comparison
lipid
belong
diacylglycerol
dag
triacylglycerol
tag
uniqu
differ
vs
mockinfect
cell
lipid
belong
sm
ffa
tag
lpe
etherp
uniqu
differ
vs
mockinfect
cell
lipid
belong
etherp
pc
uniqu
differ
vs
cell
figur
addit
lipid
belong
tag
ffa
lpc
significantli
differ
vs
mockinfect
cell
figur
taken
togeth
result
show
biogenesi
divers
intracellular
lipid
significantli
perturb
upon
infect
character
signific
lipid
perturb
infect
next
compar
direct
magnitud
statist
signific
lipid
chang
rd
cell
mockinfect
cell
fourhour
post
infect
hpi
figur
cell
exhibit
total
significantli
perturb
lipid
belong
four
lipid
class
includ
ffa
dag
lpc
tag
significantli
upregul
hpi
figur
tabl
cell
exhibit
total
perturb
lipid
belong
lipid
class
includ
cl
ffa
etherlpc
etherlp
etherp
lpc
lpe
tag
pc
sm
except
pc
significantli
upregul
infect
among
identifi
lipid
class
ffa
lpc
tag
show
consist
upregul
cell
includ
total
lipid
ffa
lpc
tag
fatti
acid
known
possess
antivir
activ
dna
rna
virus
therefor
investig
potenti
antivir
effect
identifi
ffa
four
ffa
includ
arachidon
acid
aa
docosahexaeno
acid
dha
docosapentaeno
acid
dpa
eicosapentaeno
acid
epa
first
confirm
ident
aa
dha
dpa
epa
match
retent
time
rt
msm
fragment
pattern
authent
chemic
standard
boxwhisk
plot
show
aa
dha
dpa
epa
inde
exhibit
significantli
p
higher
level
sampl
hpi
figur
treat
rd
cell
aa
dha
dpa
epa
assess
antienterovir
effect
vitro
shown
figur
aa
dha
epa
exhibit
signific
p
antivir
effect
log
reduct
viral
load
cell
includ
total
lipid
ffa
lpc
tag
authent
chemic
standard
boxwhisk
plot
show
aa
dha
dpa
epa
inde
exhibit
significantli
p
higher
level
sampl
hpi
figur
treat
rd
cell
aa
dha
dpa
epa
assess
antienterovir
effect
vitro
shown
figur
aa
dha
epa
exhibit
signific
p
antivir
effect
log
reduct
viral
load
two
common
caus
hfmd
repeatedli
caus
epidem
especi
among
children
asiapacif
region
known
enterovirus
induc
massiv
remodel
intracellular
membran
viral
replic
two
common
caus
hfmd
repeatedli
caus
epidem
especi
among
children
asiapacif
region
known
enterovirus
induc
massiv
remodel
intracellular
membran
viral
replic
data
cellular
lipidom
profil
upon
infect
lack
studi
establish
ultrahigh
perform
liquid
chromatographi
uplc
msbase
lipidom
approach
character
host
cell
lipid
perturb
upon
enteroviru
infect
omicsbas
analyt
method
assess
statist
analys
show
unbias
lipidom
approach
reliabl
identifi
signific
differ
host
lipid
profil
enteroviru
infect
identifi
total
significantli
chang
lipid
belong
phospholipid
glycerolipid
fatti
acyl
sphingolipid
categori
among
mockinfect
sampl
result
show
infect
significantli
perturb
wide
rang
host
lipid
among
significantli
chang
lipid
four
fatti
acid
name
aa
dha
dpa
epa
upregul
sampl
indic
potenti
import
role
enteroviru
infect
corrobor
find
recent
report
also
show
human
rhinoviru
anoth
import
human
pathogen
picornaviru
induc
substanti
fatti
acid
modif
human
bronchial
epitheli
cell
aa
dha
dpa
epa
polyunsatur
fatti
acid
pufa
aa
pufa
dha
dpa
epa
pufa
previous
shown
pufa
play
key
role
inflammatori
process
aa
precursor
proinflammatori
mediat
prostaglandin
pg
leukotrien
lt
well
lipoxin
endogen
antiinflammatori
proresolv
molecul
reduc
tissu
injuri
chronic
inflamm
dha
epa
inhibit
lipopolysaccharideinduc
lipopeptideinduc
express
thu
inflammatori
respons
epitheli
dendrit
cell
moreov
lipid
deriv
epa
resolvin
e
seri
dha
resolvin
seri
maresin
protectin
involv
resolut
inflamm
exhibit
antiinflammatori
properti
pufa
interact
delic
manner
regul
inflammatori
respons
exampl
pufa
dha
epa
may
serv
competit
substrat
pufa
metabol
decreas
aaderiv
eicosanoid
effect
inflamm
addit
immunomodulatori
role
pufa
also
directli
regul
viru
replic
previous
demonstr
aa
linol
acid
la
could
inhibit
replic
coronavirus
includ
middl
east
respiratori
syndrom
coronaviru
merscov
human
coronaviru
similarli
pufaderiv
lipid
mediat
protectin
report
markedli
attenu
influenza
viru
replic
via
interfer
viru
rna
export
machineri
hand
inhibit
pufa
synthesi
pathway
deplet
delta
enzym
treatment
smallmolecul
inhibitor
impair
hepat
c
viru
hcv
product
indic
pufa
could
also
requir
virion
morphogenesi
investig
biolog
relev
significantli
upregul
express
pufa
context
enteroviru
infect
evalu
effect
aa
dha
dpa
epa
replic
show
three
four
pufa
aa
dha
epa
significantli
inhibit
replic
virus
corrobor
previou
observ
fatti
acid
includ
aa
possess
antivir
activ
coronavirus
taken
togeth
result
suggest
like
coronavirus
might
modul
specif
lipid
pathway
host
lipid
profil
achiev
intric
homeostasi
facilit
replic
excess
exogen
addit
lipid
might
therefor
disrupt
delic
homeostat
state
prevent
effici
viral
replic
corrobor
recent
identif
sterol
regulatori
elementbind
protein
srebp
broadspectrum
antivir
treatment
precis
manipul
host
lipid
profil
might
therefor
potenti
hosttarget
antivir
strategi
enteroviru
infect
rd
atcc
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
heatinactiv
fetal
bovin
serum
fb
penicillin
streptomycin
incub
co
c
archiv
clinic
isol
isol
patient
hfmd
avail
depart
microbiolog
univers
hong
kong
virus
cultur
rd
cell
serumfre
dmem
supplement
uml
penicillin
gml
streptomycin
supernat
harvest
cytopath
effect
cpe
observ
centrifug
gener
viral
stock
viru
stock
titrat
plaqu
assay
cell
store
c
previous
describ
briefli
confluent
cell
infect
serial
viral
dilut
cell
incub
dilut
virus
c
h
subsequ
overlaid
lowmeltingpoint
agaros
promega
madison
wi
usa
cell
fix
formaldehyd
plaqu
observ
stain
crystal
violet
experi
involv
live
follow
approv
standard
oper
procedur
biosafeti
level
facil
depart
microbiolog
univers
hong
kong
previous
describ
chemic
reagent
standard
hplc
prepar
previous
describ
briefli
hplcgrade
methanol
acetonitril
chloroform
isopropanol
purchas
merck
darmstadt
germani
milliq
water
purif
system
millipor
burlington
usa
use
prepar
hplcgrade
water
analyt
grade
formic
acid
ammonium
format
commerci
standard
use
biomark
identif
purchas
sigmaaldrich
lipid
treatment
virusinfect
cell
perform
previous
describ
modif
briefli
rd
cell
seed
plate
reach
confluenc
infect
cell
preincub
lipidsuppl
medium
follow
concentr
h
aa
dpa
dha
epa
cell
infect
either
multipl
infect
moi
hpi
cell
wash
three
time
dmem
cell
replenish
lipidsuppl
medium
h
incub
cell
lysat
collect
qrtpcr
confluent
rd
cell
infect
moi
incub
dmem
medium
mockinfect
rd
cell
use
control
cell
four
biolog
replic
per
group
collect
cellular
lipid
extract
hpi
lipid
extract
perform
liquid
chromatographymass
spectrometri
lcm
analysi
accord
previous
describ
protocol
slight
modif
briefli
icecold
mm
ammonium
bicarbon
solut
ad
dissoci
cell
cell
suspens
use
dna
extract
normal
total
methanol
contain
butyl
hydroxytoluen
bht
ad
well
ml
chloroformmethanol
vv
ad
follow
vortex
centrifug
rpm
min
c
bottom
phase
transfer
glass
vial
dri
labconco
centrivap
cold
trap
concentr
storag
dri
sampl
reconstitut
chloroformmethanol
vv
dilut
origin
concentr
cell
lysat
ipaacnwat
vvv
lcm
analysi
inactiv
viru
infect
confirm
process
previous
describ
modif
uplcesiqtofm
analysi
perform
previous
describ
slight
modif
briefli
lipid
extract
analyz
use
acquiti
uplc
system
coupl
synapt
high
definit
mass
spectrometri
hdm
system
water
corp
milford
usa
chromatographi
perform
water
acquiti
csh
column
mm
coupl
acquiti
csh
vanguard
precolumn
mm
water
milford
usa
mobil
phase
acetonitril
water
vv
mm
ammonium
format
formic
acid
mobil
phase
b
posit
mode
isopropanol
acetonitril
vv
mm
ammonium
format
formic
acid
mobil
phase
b
neg
mode
isopropanol
acetonitril
vv
mm
ammonium
acet
gradient
elut
appli
uplcm
analysi
describ
tabl
column
autosampl
temperatur
maintain
c
c
respect
inject
volum
mass
spectral
data
acquir
posit
neg
mode
capillari
voltag
maintain
posit
mode
kv
neg
mode
sampl
cone
voltag
sourc
offset
maintain
v
v
respect
nitrogen
use
desolv
ga
flow
rate
lh
sourc
desolv
temperatur
maintain
c
c
respect
mass
spectra
acquir
mz
rang
synapt
hdm
system
calibr
use
sodium
format
cluster
oper
sensit
mode
leucin
enkephalin
use
lock
mass
experi
msm
acquisit
oper
paramet
ms
acquisit
collis
energi
appli
rang
ev
fragment
allow
put
identif
structur
elucid
signific
lipid
investig
lipid
detect
extract
capac
current
method
total
lipid
intern
standard
appli
sampl
prepar
lcm
analysi
monitor
lipid
coverag
extract
effici
addit
check
stabil
lcm
system
analyt
batch
qc
sampl
inject
begin
run
everi
six
sampl
monitor
system
variat
qc
sampl
prepar
pool
equal
aliquot
sampl
current
studi
acquisit
raw
data
perform
use
masslynx
softwar
version
water
corp
usa
raw
data
convert
analysi
base
file
abf
format
reifyc
abf
convert
softwar
http
wwwreifycscomabfconvert
abf
data
process
gener
usabl
data
matrix
includ
annot
lipid
name
accur
mass
retent
time
correspond
intens
uniqu
ms
featur
msdial
softwar
http
primepscrikenjpmetabolomicssoftwaremsdi
data
matrix
export
csv
file
statist
analysi
metaboanalyst
http
wwwmetaboanalystca
simcap
umetr
sweden
use
univari
multivari
analysi
respect
univari
analysi
statist
signific
featur
determin
compar
mockinfect
virusinfect
group
use
student
ttest
fold
chang
adjust
pvalu
fold
chang
use
criteria
select
signific
featur
multivari
analysi
featur
first
subject
pareto
scale
follow
orthogon
partial
least
squar
discrimin
analysi
oplsda
find
import
variabl
discrimin
power
variabl
import
project
vip
score
use
criterion
signific
lipid
featur
select
repres
xy
variabl
explan
rate
predict
abil
oplsda
model
respect
calcul
use
simcap
softwar
identif
lipid
perform
previous
describ
briefli
msm
fragment
perform
signific
featur
high
abund
signific
featur
identifi
search
accur
ms
msm
fragment
pattern
data
msdial
intern
lipid
databas
massbank
north
america
mona
http
monafiehnlabucdavisedu
metlin
databas
http
metlinscrippsedu
lipid
map
http
wwwlipidmapsorg
confirm
lipid
ident
use
authent
chemic
standard
msm
fragment
pattern
chemic
standard
compar
candid
lipid
measur
lcm
condit
summari
establish
exploit
reliabl
unbias
lipidom
approach
character
host
lipidom
profil
chang
upon
infect
find
significantli
upregul
express
pufa
infect
provid
novel
understand
pathogenesi
hosttarget
antivir
strategi
enteroviru
infect
